U.S. FDA declines to approve Cytokinetics' heart drug

Royalty Pharma

28/02/2023 22:39

Feb 28 (Reuters) - Cytokinetics Inc  CYTK.O  said on
Tuesday the U.S health regulator declined to approve its oral
drug for a type of heart failure, citing lack of sufficient data
to show the drug was effective. 
    The U.S. Food and Drug Administration's decision comes after
a panel of outside experts in December recommended against
allowing the use of the drug due to safety concerns. 

 (Reporting by Pratik Jain and Bhanvi Satija in Bengaluru;
Editing by Shinjini Ganguli)
 ((Pratik.Jain@thomsonreuters.com;))